Addison Capital’s Pfizer PFE Stock Holding History

Addison Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$625K	Buy	25,956 +7	+0%	+$183	0.1%	134
2026 Q1	$729K	Buy	25,949 +753	+3%	+$20K	0.13%	122
2025 Q4	$627K	Sell	25,196 -1,593	-6%	-$40.2K	0.16%	97
2025 Q3	$683K	Buy	+26,789	New	+$661K	0.2%	91
2023 Q1	–	Sell	-4,272	Closed	-$219K	–	120
2022 Q4	$219K	Buy	+4,272	New	+$205K	0.14%	111
2022 Q3	–	Sell	-4,252	Closed	-$223K	–	132
2022 Q2	$223K	Sell	4,252 -82	-2%	-$4.18K	0.13%	117
2022 Q1	$224K	Buy	4,334 +501	+13%	+$26K	0.11%	127
2021 Q4	$226K	Buy	+3,833	New	+$190K	0.1%	125
2015 Q2	–	Sell	-40,669	Closed	-$1.34M	–	95
2015 Q1	$1.34M	Sell	40,669 -523	-1%	-$16.6K	1.09%	40
2014 Q4	$1.22M	Sell	41,192 -2,294	-5%	-$65.8K	1.03%	41
2014 Q3	$1.22M	Buy	43,486 +1,482	+4%	+$41.6K	1.07%	42
2014 Q2	$1.18M	Sell	42,004 -1,436	-3%	-$40.9K	1.02%	44
2014 Q1	$1.32M	Buy	43,440 +1,188	+3%	+$35.4K	1.13%	41
2013 Q4	$1.23M	Buy	+42,252	New	+$1.23M	1.13%	38

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Addison Capital's PFE Position: Q2 2026 in Review

Addison Capital increased its Pfizer (PFE) stake by 0.03% in Q2 2026, buying an estimated $183 and bringing the position to 25,956 shares worth $625K. The position accounts for 0.1% of the portfolio, ranked #134.

Addison Capital first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $1.34M in Q1 2015. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Addison Capital held 25,956 shares of Pfizer worth $625K as of Q2 2026.
Addison Capital bought 7 Pfizer shares in Q2 2026, an estimated $183.
Pfizer made up 0.1% of Addison Capital's portfolio in Q2 2026, its #134 holding.
Addison Capital first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
Addison Capital's Pfizer position peaked at $1.34M in Q1 2015.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Addison Capital's 13F filing for Q2 2026, filed 4 Aug 2026.